Noteworthy in this regard is the involvement of JNK3 (MAPK10) in these signaling events and has been verified by our JNK3 protein kinase inhibition experiment showing that the repression of the JNK3 expression is essential for the enhancement of PTX toxicity in cancer cells. The gene discussed is MAPK10; the disease is cancer.